Drug General Information
Drug ID
D0S0GM
Former ID
DIB006484
Drug Name
ADX-10061
Synonyms
CEE-310; NNC-687; NO-687; CEE-03-310; NNC-01-0687; NNC-01-687
Indication Psychotic disorders [ICD9: 290-299; ICD10:F20-F29] Discontinued in Phase 2 [544910]
Company
Addex Pharmaceuticals; Novo Nordisk A/S
Structure
Download
2D MOL

3D MOL

Canonical SMILES
c1([N+](=O)[O-])cc2c([C@@H](c3c4OCCc4ccc3)CN(CC2)C)cc1O
CAS Number
CAS 128022-68-4
Target and Pathway
Target(s) Dopamine D1 receptor Target Info Antagonist [544911]
KEGG Pathway Calcium signaling pathway
cAMP signaling pathway
Neuroactive ligand-receptor interaction
Gap junction
Dopaminergic synapse
Parkinson's disease
Cocaine addiction
Amphetamine addiction
Morphine addiction
Alcoholism
PANTHER Pathway Dopamine receptor mediated signaling pathway
PathWhiz Pathway Dopamine Activation of Neurological Reward System
Reactome Dopamine receptors
G alpha (s) signalling events
WikiPathways Hypothetical Network for Drug Addiction
Monoamine GPCRs
GPCRs, Class A Rhodopsin-like
Genes and (Common) Pathways Underlying Drug Addiction
GPCR ligand binding
GPCR downstream signaling
References
Ref 544910Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800001476)
Ref 544911Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800001476)

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.